Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong · Delayed Price · Currency is HKD 27.58
-2.02 (-6.82%)
Aug 21, 2026, 4:08 PM HKT
Giant Biogene Holding Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 29,282 | 35,467 | 50,360 | 34,746 | 32,794 | - | |
Market Cap Growth | -50.07% | -29.57% | 44.94% | 5.95% | - | - |
Enterprise Value | 20,773 | 25,777 | 43,851 | 31,750 | 31,531 | - |
Last Close Price | 27.58 | 31.74 | 46.52 | 32.52 | 30.69 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.19 | 16.64 | 22.95 | 21.73 | 41.68 | - |
Forward PE | 12.32 | 12.61 | 19.66 | 19.71 | 26.93 | - |
PS Ratio | 4.76 | 5.78 | 8.54 | 8.95 | 12.27 | - |
PB Ratio | 2.71 | 3.21 | 6.65 | 7.22 | 10.23 | - |
P/TBV Ratio | 2.71 | 3.22 | 6.66 | 7.24 | 10.26 | - |
P/FCF Ratio | - | 23.56 | 26.37 | 22.19 | 37.24 | - |
P/OCF Ratio | - | 17.90 | 23.18 | 19.14 | 31.14 | - |
PEG Ratio | 1.27 | 1.94 | 0.85 | 0.78 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.38 | 4.20 | 7.44 | 8.18 | 11.80 | - |
EV/EBITDA Ratio | 10.08 | 10.55 | 17.72 | 17.54 | 24.07 | - |
EV/EBIT Ratio | 10.54 | 10.92 | 18.06 | 17.88 | 24.61 | - |
EV/FCF Ratio | - | 17.13 | 22.96 | 20.28 | 35.80 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
Debt / EBITDA Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | - |
Debt / FCF Ratio | - | 0.01 | 0.00 | 0.00 | 0.00 | - |
Net Debt / Equity Ratio | -0.79 | -0.84 | -0.82 | -0.87 | -0.78 | -7.14 |
Net Debt / EBITDA Ratio | -4.18 | -3.79 | -2.52 | -2.31 | -1.91 | -7.78 |
Net Debt / FCF Ratio | - | -6.15 | -3.27 | -2.66 | -2.84 | -11.76 |
Asset Turnover | 0.50 | 0.59 | 0.85 | 0.87 | 0.43 | 0.30 |
Inventory Turnover | 2.80 | 3.09 | 3.88 | 3.00 | 2.70 | 2.57 |
Quick Ratio | 9.96 | 10.70 | 7.21 | 7.36 | 8.16 | 1.07 |
Current Ratio | 10.63 | 11.27 | 7.66 | 7.79 | 9.03 | 1.09 |
Return on Equity (ROE) | 18.01% | 22.47% | 35.88% | 40.18% | 51.98% | 112.30% |
Return on Assets (ROA) | 9.80% | 14.04% | 21.92% | 24.84% | 12.86% | 10.81% |
Return on Invested Capital (ROIC) | 70.93% | 121.07% | 208.92% | 221.93% | - | - |
Return on Capital Employed (ROCE) | 17.80% | 21.10% | 31.70% | 36.30% | 39.70% | 88.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.59% | 6.01% | 4.36% | 4.60% | 3.45% | - |
FCF Yield | - | 4.24% | 3.79% | 4.51% | 2.69% | - |
Dividend Yield | 4.96% | 1.89% | 1.38% | 1.49% | - | - |
Payout Ratio | - | 33.67% | 44.05% | - | 36.67% | 307.92% |
Buyback Yield / Dilution | -4.18% | -5.76% | -1.93% | 3.77% | -2.03% | -0.09% |
Total Shareholder Return | 0.77% | -3.87% | -0.55% | 5.26% | -2.03% | -0.09% |